XML 52 R37.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stock Based Compensation (Tables)
12 Months Ended
Dec. 31, 2018
Summary of changes in outstanding restricted stock units

 

 

 

 

 

 

 

    

 

    

  Weighted-

 

 

 

 

Average

 

 

 

 

Grant-Date

 

 

Shares 

 

Fair Value

Outstanding as of December 31, 2017

 

49,677

 

$

16.20

Granted

 

75,188

 

 

2.66

Vested

 

(25,928)

 

 

10.63

Forfeited

 

(30,288)

 

 

9.91

Outstanding as of December 31, 2018

 

68,649

 

$

6.25

 

Schedule of vesting for unvested restricted stock units

 

 

 

2019

 

57,563

2020

 

10,843

2021

 

243

 Total unvested restricted stock units as December 31, 2018

 

68,649

 

Summary of changes in number of outstanding cash performance units

 

 

 

 

 

    

 

    

 

 

 

 

 

 

 

 

 

 

Shares 

 

Outstanding as of December 31, 2017

 

822,915

 

Granted

 

 —

 

Vested

 

(274,854)

 

Forfeited

 

(123,049)

 

Outstanding as of December 31, 2018

 

425,012

 

 

 

 

 

 

Omnibus Plan  
Summary of outstanding and exercisable stock options

 

 

 

 

 

 

 

 

 

 

 

    

 

    

 

 

 

 

Weighted-

    

 

 

 

 

Weighted-

 

 

Average

 

 

 

 

 

Average

 

 

Remaining

 

 

 

 

 

Exercise

 

 

Contractual Term

 

 

 

Options

 

Price

 

 

(in Years)

 

 

 

 

 

 

 

 

 

 

 

Outstanding as of December 31, 2017

 

937,310

 

$

17.11

 

 

 

 

Granted

 

159,755

 

 

2.74

 

 

 

 

Forfeited

 

(186,438)

 

 

15.17

 

 

 

 

Outstanding as of December 31, 2018

 

910,627

 

$

14.99

 

 

8.38

 

Options vested and exercisable as of December 31, 2018

 

305,275

 

 

23.04

 

 

7.93

 

Options vested and expected to vest as of December 31, 2018

 

910,627

 

 

14.99

 

 

8.38

 

 

Summary of activity in non-vested stock options

 

 

 

 

 

 

 

    

 

    

 

 

 

 

 

 

Weighted-

 

 

 

 

Average

 

 

 

 

Grant-Date

 

 

Number

 

Fair Value

Non-vested as of December 31, 2017

 

876,903

 

$

4.08

Granted

 

159,755

 

 

1.21

Forfeited

 

(152,242)

 

 

3.45

Vested

 

(279,064)

 

 

4.81

Non-vested as of December 31, 2018

 

605,352

 

$

3.14

 

 

 

 

 

 

 

Schedule of vesting for unvested options

 

 

 

2019

 

301,267

2020

 

250,228

2021

 

53,857

2022

 

 -

Total unvested options as of December 31, 2018

 

605,352

 

Schedule of valuation assumptions

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year ended December 31,

 

 

2018

 

2017

Expected term in years

 

6.0

 

 

6.0

 

Volatility

 

48.0

%

 

31.9

%

Risk-free interest rate

 

2.7

%

 

2.0

%

Dividend yield(1)

 

 -

%

 

0.9

%

(1)

Represents the weighted-average dividend yield for grants made during the year ended December 31, 2017.  The Company discontinued its quarterly dividend program during August 2017. 

Weighted average grant date fair value of options granted

 

 

 

 

 

 

 

 

 

Year Ended December 31,

 

 

2018

 

 

2017

 

Weighted Average Grant-Date Fair Value of Options Granted

$

1.21

 

$

2.43